Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Total Liabilities: 2009-2024

Historic Total Liabilities for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $920.0 million.

  • UNITED THERAPEUTICS's Total Liabilities fell 25.56% to $760.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $760.9 million, marking a year-over-year decrease of 25.56%. This contributed to the annual value of $920.0 million for FY2024, which is 22.18% down from last year.
  • As of FY2024, UNITED THERAPEUTICS's Total Liabilities stood at $920.0 million, which was down 22.18% from $1.2 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Total Liabilities registered a high of $1.2 billion during FY2022, and its lowest value of $920.0 million during FY2024.
  • For the 3-year period, UNITED THERAPEUTICS's Total Liabilities averaged around $1.1 billion, with its median value being $1.2 billion (2023).
  • In the last 5 years, UNITED THERAPEUTICS's Total Liabilities rose by 7.66% in 2020 and then fell by 22.18% in 2024.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Total Liabilities stood at $1.2 billion in 2020, then fell by 0.79% to $1.2 billion in 2021, then climbed by 3.11% to $1.2 billion in 2022, then declined by 5.26% to $1.2 billion in 2023, then decreased by 22.18% to $920.0 million in 2024.